+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bifurcation Lesion"

From
Bifurcation Lesions - Global Strategic Business Report - Product Thumbnail Image

Bifurcation Lesions - Global Strategic Business Report

  • Report
  • May 2024
  • 93 Pages
  • Global
From
Bifurcation Lesions Global Market Report 2024 - Product Thumbnail Image

Bifurcation Lesions Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
From
From
From
Bifurcation Stenting. Edition No. 1 - Product Thumbnail Image

Bifurcation Stenting. Edition No. 1

  • Book
  • March 2012
  • 216 Pages
  • 15 Results (Page 1 of 1)
Loading Indicator

The Bifurcation Lesion market is a segment of the Cardiovascular Devices industry that focuses on the treatment of bifurcation lesions. Bifurcation lesions are a type of coronary artery disease that occurs when a single artery divides into two branches. Treatment of these lesions requires specialized devices that can be used to deliver stents to both branches of the artery. These devices are designed to provide improved outcomes for patients with bifurcation lesions. The Bifurcation Lesion market is highly competitive, with a number of companies offering a range of products. These products include stents, balloons, guidewires, and other accessories. Companies in the market are focused on developing innovative products that can improve patient outcomes and reduce the risk of complications. Some of the major companies in the Bifurcation Lesion market include Abbott, Boston Scientific, Medtronic, and Terumo. These companies are leading the way in developing new products and technologies to improve the treatment of bifurcation lesions. Show Less Read more